-
Story /In Cameroon, seeking treatment for chronic diseases can be a long journey.
-
Press release /WHO prequalified Coartem® 80/480mg is the first and only high strength malaria treatment available for donor-funded public sector procurement Coartem® 80/480mg reduces the pill burden for…
-
Story /In Guatemala, social worker Eduardo Canuz fights logistical and cultural challenges while preventing women and infants from inhaling smoke.
-
Story /New Global Head of Cardiovascular and Metabolic Diseases Research looks to apply new tools to address tough challenges.
-
Press release /The digital press release with multimedia content can be accessed here: Basel, May 15, 2018 - Novartis AG (NYSE: NVS) ("Novartis") today announced that it has completed the acquisition of…
-
Event /At this year’s American Society of Clinical Oncology Annual Meeting (ASCO), we will be sharing the latest oncology portfolio data, research, and science around how we are reimagining medicine.Learn…
-
Story /Graf explains how flexible working has contributed to her success.
-
Story /Cardiovascular disease is the leading cause of death in the US, claiming one in four lives. Social factors such as living conditions, education and diet play a key role in determining a person’s heart health, which means cardiovascular disease typically hits vulnerable communities the hardest. Our three-year Closing the Gap initiative with the Jefferson Collaborative for Health Equity (established by Jefferson Health and Thomas Jefferson University) focuses on addressing the upstream social determinants of heart health in five vulnerable neighborhoods in Philadelphia with high rates of stroke and adverse outcomes related to heart disease.
-
Press release /More than 27,000 Novartis associates worldwide dedicate an estimated 200,000 hours to volunteer with charitable causes in their communities Community Partnership Day symbolizes the company'…
Pagination
- ‹ Previous page
- 1
- …
- 127
- 128
- 129
- 130
- 131
- 132
- 133
- …
- 139
- › Next page